Objective Transitions in the spectrum of valvular heart diseases (VHDs) in developed countries over the 20th century have been reported from clinical case series, but large, contemporary ...
Background Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and ...
Objective Advance care planning (ACP) is widely advocated to contribute to better outcomes for patients suffering from heart failure. But clinicians appear hesitant to engage with ACP. Our aim was to ...
Mitral annular calcification (MAC) is a progressive, degenerative process increasingly recognised for its clinical impact.
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
Correspondence to Dr Prachi Bhatnagar, British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention, Nuffield Department of Population Health, Old Road Campus, ...
Background Non-dilated left ventricular cardiomyopathy (NDLVC), characterised by non-ischaemic scar/fatty replacement or isolated systolic dysfunction without dilatation, lacks validated risk ...
Objective Distinguishing early dilated cardiomyopathy (DCM) from physiological left ventricular (LV) dilatation with LV ejection fraction <55% in athletes (grey zone) is challenging. We evaluated the ...
Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as the primary reason for admission. To allow comparison of outcomes between ...
Infective endocarditis (IE) is a complex and severe disease with in-hospital mortality plateauing at ∼20% and 1 year mortality up to 40% in most contemporary cohorts. Although 60–70% of patients with ...
Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its ...
Percutaneous ventricular assist devices (pVADs) provide short-term mechanical circulatory support and therefore have potential utility during elective, high-risk percutaneous coronary intervention ...